Mounting evidence suggests that G-protein-coupled receptors (GPCRs), such as CXC chemokine receptor 1/2 (CXCR1/2), are the mutual receptors of GROα in human cancers, including ovarian tumors [41–43]. The gene discussed is CXCL1; the disease is cancer.